Skip to content

Insider · CIK 0001853544

Walts Alan Edmund

Reports to the SEC for 1 company · ARLINGTON, MA

Transactions

15

Companies

1

Filings

10

CIK

0001853544

Forms 4 and 5

Insider transactions

15 trades
DateCompanyValue
2026-06-08ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2026-01-24ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion—
2026-01-24ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2025-09-19ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2025-01-24ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion—
2025-01-24ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2024-10-16ELOXEloxx Pharmaceuticals, Inc.A Award—
2024-01-24ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsA Award—
2023-01-30ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award—
2022-06-15ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award—
2021-12-01ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion—
2021-12-01ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2021-05-19ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2021-04-01ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsA Award—
2021-04-01ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award—

Recent filings

10

Companies

1

Address

C/O ELOXX PHARMACEUTICALS, INC. P.O. BOX 274

ARLINGTON, MA, 02476